Countries' Act | West FY 22 Work Plans

The FY22 Work Plan each country covers October 1, 2021 - September 30, 2022, the fourth year of the five-year program. The fourth-year work plan continues to build on the previous achievements of the program and consider lessons learned.  It aims to achieve the following three intermediate results (IRs):

IR1: Increased mass drug administration (MDA) coverage among at-risk populations in endemic countries
IR2: Strengthened country environment for implementation and management of national NTD programs (NTDPs)
IR3: Sustained MDA coverage among at-risk populations in endemic countries

 

Act West FY22 Workplan-Benin.pdf

Act West FY22 Workplan-Burkina Faso.pdf

Act West FY22 Workplan-Cameroon.pdf

Act West FY22 Workplan-Cote d'Ivoire.pdf

Act West FY22 Workplan-Ghana.pdf

Act West FY22 Workplan-Guinea.pdf

Act West FY22 Workplan-Mali.pdf

Act West FY22 Workplan-Niger.pdf

Act West FY22 Workplan-Senegal.pdf

Act West FY22 Workplan-Sierra Leone.pdf

Act West FY22 Workplan-Togo.pdf

Act to End NTDs West logo
TypeWork PlanYear of publication DiseaseAll Preventive Chemotherapy NTDsCountryAll Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, TogoFocus AreasMass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier developmentPartnersAIM Initiative, Deloitte, FHI360, HDI, HKI, World Vision